{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:11:25Z","timestamp":1786983085879,"version":"build-2736575974"},"reference-count":197,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s43440-026-00855-5","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:52:49Z","timestamp":1777956769000},"page":"679-706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prospects and challenges in intracellular delivery of therapeutic proteins"],"prefix":"10.1007","volume":"78","author":[{"given":"Zakia","family":"Sultana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashif","family":"Ahamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muddasarul","family":"Hoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safdar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8450-7738","authenticated-orcid":false,"given":"Mehboob","family":"Hoque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"issue":"9","key":"855_CR1","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3390\/molecules25092193","volume":"25","author":"AA Yetisgin","year":"2020","unstructured":"Yetisgin AA, Cetinel S, Zuvin M, Kosar A, Kutlu O. Therapeutic nanoparticles and their targeted delivery applications. Molecules. 2020;25(9):2193. https:\/\/doi.org\/10.3390\/molecules25092193.","journal-title":"Molecules"},{"key":"855_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.addr.2020.08.008","volume":"156","author":"A Varanko","year":"2020","unstructured":"Varanko A, Saha S, Chilkoti A. Recent trends in protein and peptide-based biomaterials for advanced drug delivery. Adv Drug Deliv Rev. 2020;156:133\u201387. https:\/\/doi.org\/10.1016\/j.addr.2020.08.008.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"855_CR3","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","volume":"5","author":"AM Vargason","year":"2021","unstructured":"Vargason AM, Anselmo AC, Mitragotri S. The evolution of commercial drug delivery technologies. Nat Biomed Eng. 2021;5(9):951\u201367. https:\/\/doi.org\/10.1038\/s41551-021-00698-w.","journal-title":"Nat Biomed Eng"},{"key":"855_CR4","doi-asserted-by":"publisher","first-page":"103628","DOI":"10.1016\/j.critrevonc.2022.103628","volume":"172","author":"D Ferreira","year":"2022","unstructured":"Ferreira D, Moreira JN, Rodrigues LR. New advances in exosome-based targeted drug delivery systems. Crit Rev Oncol\/Hematol. 2022;172:103628. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103628.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"1","key":"855_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","volume":"7","author":"L Wang","year":"2022","unstructured":"Wang L, Wang N, Zhang W, Cheng X, Yan Z, Shao G, et al. Therapeutic peptides: current applications and future directions. Sig Transduct Target Ther. 2022;7(1):48. https:\/\/doi.org\/10.1038\/s41392-022-00904-4.","journal-title":"Sig Transduct Target Ther"},{"key":"855_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.actbio.2023.09.018","volume":"171","author":"TTK Nguyen","year":"2023","unstructured":"Nguyen TTK, Pham K-Y, Yook S. Engineered therapeutic proteins for sustained-release drug delivery systems. Acta Biomater. 2023;171:131\u201354. https:\/\/doi.org\/10.1016\/j.actbio.2023.09.018.","journal-title":"Acta Biomater"},{"issue":"4","key":"855_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s13205-024-03958-z","volume":"14","author":"V Kumar","year":"2024","unstructured":"Kumar V, Barwal A, Sharma N, Mir DS, Kumar P, Kumar V. Therapeutic proteins: developments, progress, challenges, and future perspectives. 3 Biotech 2024. 3 Biotech. 2024;14(4):112. https:\/\/doi.org\/10.1007\/s13205-024-03958-z.","journal-title":"3 Biotech"},{"issue":"7624","key":"855_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nature19764","volume":"538","author":"MP Stewart","year":"2016","unstructured":"Stewart MP, Sharei A, Ding X, Sahay G, Langer R, Jensen KF. In vitro and ex vivo strategies for intracellular delivery. Nature. 2016;538(7624):183\u201392. https:\/\/doi.org\/10.1038\/nature19764.","journal-title":"Nature"},{"issue":"22","key":"855_CR9","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.3390\/cancers14225546","volume":"14","author":"RA Bottens","year":"2022","unstructured":"Bottens RA, Yamada T. Cell-penetrating peptides (CPPs) as therapeutic and diagnostic agents for cancer. Cancers. 2022;14(22):5546. https:\/\/doi.org\/10.3390\/cancers14225546.","journal-title":"Cancers"},{"issue":"77","key":"855_CR10","doi-asserted-by":"publisher","first-page":"11473","DOI":"10.1039\/D0CC04728G","volume":"56","author":"SS Liew","year":"2020","unstructured":"Liew SS, Zhang C, Zhang J, Sun H, Li L, Yao SQ. Intracellular delivery of therapeutic proteins through N-terminal site-specific modification. Chem Commun. 2020;56(77):11473\u201376. https:\/\/doi.org\/10.1039\/D0CC04728G.","journal-title":"Chem Commun"},{"issue":"23","key":"855_CR11","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1002\/anie.201902347","volume":"58","author":"SR Jakka","year":"2019","unstructured":"Jakka SR, Govindaraj V, Mugesh G. A single atom change facilitates the membrane transport of green fluorescent proteins in mammalian cells. Angew Chem Int Ed. 2019;58(23):7713\u201317. https:\/\/doi.org\/10.1002\/anie.201902347.","journal-title":"Angew Chem Int Ed"},{"key":"855_CR12","doi-asserted-by":"publisher","first-page":"032019","DOI":"10.1088\/1757-899X\/263\/3\/032019","volume":"263","author":"S Anu Mary Ealia","year":"2017","unstructured":"Anu Mary Ealia S, Saravanakumar MP. A review on the classification, characterisation, synthesis of nanoparticles and their application. IOP Conf Ser: Mater Sci Eng. 2017;263:032019. https:\/\/doi.org\/10.1088\/1757-899X\/263\/3\/032019.","journal-title":"IOP Conf Ser: Mater Sci Eng"},{"issue":"8","key":"855_CR13","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1002\/anie.201907484","volume":"59","author":"S Pottanam Chali","year":"2020","unstructured":"Pottanam Chali S, Ravoo BJ. Polymer nanocontainers for intracellular delivery. Angew Chem Int Ed. 2020;59(8):2962\u201372. https:\/\/doi.org\/10.1002\/anie.201907484.","journal-title":"Angew Chem Int Ed"},{"issue":"1","key":"855_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","volume":"27","author":"R-M Lu","year":"2020","unstructured":"Lu R-M, Hwang Y-C, Liu I-J, Lee C-C, Tsai H-Z, Li H-J, et al. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci. 2020;27(1):1. https:\/\/doi.org\/10.1186\/s12929-019-0592-z.","journal-title":"J Biomed Sci"},{"issue":"1","key":"855_CR15","doi-asserted-by":"publisher","first-page":"18688","DOI":"10.1038\/s41598-019-55091-0","volume":"9","author":"J Gaston","year":"2019","unstructured":"Gaston J, Maestrali N, Lalle G, Gagnaire M, Masiero A, Dumas B, et al. Intracellular delivery of therapeutic antibodies into specific cells using antibody-peptide fusions. Sci Rep. 2019;9(1):18688. https:\/\/doi.org\/10.1038\/s41598-019-55091-0.","journal-title":"Sci Rep"},{"key":"855_CR16","doi-asserted-by":"publisher","first-page":"0035","DOI":"10.34133\/bmef.0035","volume":"5","author":"A Chan","year":"2024","unstructured":"Chan A, Tsourkas A. Intracellular protein delivery: approaches, challenges, and clinical applications. BME Front. 2024;5:0035. https:\/\/doi.org\/10.34133\/bmef.0035.","journal-title":"BME Front"},{"issue":"25","key":"855_CR17","doi-asserted-by":"publisher","first-page":"2300319","DOI":"10.1002\/adhm.202300319","volume":"12","author":"TB Gandek","year":"2023","unstructured":"Gandek TB, Van Der Koog L, Nagelkerke A. A Comparison of cellular uptake mechanisms, delivery efficacy, and intracellular fate between liposomes and extracellular vesicles. Adv Healthcare Mater. 2023;12(25):2300319. https:\/\/doi.org\/10.1002\/adhm.202300319.","journal-title":"Adv Healthcare Mater"},{"key":"855_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.biochi.2023.05.011","volume":"213","author":"V Graceffa","year":"2023","unstructured":"Graceffa V. Intracellular protein delivery: new insights into the therapeutic applications and emerging technologies. Biochimie. 2023;213:82\u201399. https:\/\/doi.org\/10.1016\/j.biochi.2023.05.011.","journal-title":"Biochimie"},{"issue":"5\u20136","key":"855_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.drudis.2010.01.009","volume":"15","author":"AR Menjoge","year":"2010","unstructured":"Menjoge AR, Kannan RM, Tomalia DA. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov. Today Today. 2010;15(5\u20136):171\u201385. https:\/\/doi.org\/10.1016\/j.drudis.2010.01.009.","journal-title":"Drug Discov. Today Today"},{"issue":"1","key":"855_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/10717544.2019.1582730","volume":"26","author":"R Zhang","year":"2019","unstructured":"Zhang R, Qin X, Kong F, Chen P, Pan G. Improving cellular uptake of therapeutic entities through interaction with components of cell membrane. Drug Deliv. 2019;26(1):328\u201342. https:\/\/doi.org\/10.1080\/10717544.2019.1582730.","journal-title":"Drug Deliv"},{"issue":"3","key":"855_CR21","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/pharmaceutics16030422","volume":"16","author":"H Zhang","year":"2024","unstructured":"Zhang H, Ge A, Wang Y, Xia B, Wang X, Zheng Z, et al. Intracellular delivery of therapeutic protein via ultrathin layered Double hydroxide nanosheets. Pharmaceutics. 2024;16(3):422. https:\/\/doi.org\/10.3390\/pharmaceutics16030422.","journal-title":"Pharmaceutics"},{"issue":"5","key":"855_CR22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3892\/br.2016.639","volume":"4","author":"Z Guo","year":"2016","unstructured":"Guo Z, Peng H, Kang J, Sun D. Cell-penetrating peptides: possible transduction mechanisms and therapeutic applications. Biomed Rep. 2016;4(5):528\u201334. https:\/\/doi.org\/10.3892\/br.2016.639.","journal-title":"Biomed Rep"},{"issue":"8","key":"855_CR23","doi-asserted-by":"publisher","first-page":"19518","DOI":"10.3390\/ijms160819518","volume":"16","author":"H Li","year":"2015","unstructured":"Li H, Tsui T, Ma W. Intracellular delivery of molecular cargo using cell-penetrating peptides and the combination strategies. IJMS. 2015;16(8):19518\u201336. https:\/\/doi.org\/10.3390\/ijms160819518.","journal-title":"IJMS"},{"issue":"1","key":"855_CR24","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1038\/s41467-021-25448-z","volume":"12","author":"S Yu","year":"2021","unstructured":"Yu S, Yang H, Li T, Pan H, Ren S, Luo G, et al. Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo. Nat Commun. 2021;12(1):5131. https:\/\/doi.org\/10.1038\/s41467-021-25448-z.","journal-title":"Nat Commun"},{"issue":"11","key":"855_CR25","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.3390\/molecules22111929","volume":"22","author":"D Kalafatovic","year":"2017","unstructured":"Kalafatovic D, Giralt E. Cell-penetrating peptides: design strategies beyond primary structure and amphipathicity. Molecules. 2017;22(11):1929. https:\/\/doi.org\/10.3390\/molecules22111929.","journal-title":"Molecules"},{"key":"855_CR26","doi-asserted-by":"publisher","unstructured":"R\u00e4\u00e4gel H, Pooga M. Peptide and protein delivery with cell-penetrating peptides. Pept. Protein Deliv., Elsevier. 2011;221\u201346. https:\/\/doi.org\/10.1016\/B978-0-12-384935-9.10010-0.","DOI":"10.1016\/B978-0-12-384935-9.10010-0"},{"issue":"4\u20135","key":"855_CR27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.addr.2007.09.003","volume":"60","author":"M Hansen","year":"2008","unstructured":"Hansen M, Kilk K, Langel \u00dc. Predicting cell-penetrating peptides. Adv Drug Deliv Rev. 2008;60(4\u20135):572\u201379. https:\/\/doi.org\/10.1016\/j.addr.2007.09.003.","journal-title":"Adv Drug Deliv Rev"},{"key":"855_CR28","doi-asserted-by":"publisher","unstructured":"Agrawal P, Bhalla S, Usmani SS, Singh S, Chaudhary K, Raghava GPS, et al. Cppsite 2.0: a repository of experimentally validated cell-penetrating peptides. Nucleic Acids Res. 2016;44(D1):D1098\u2013103. https:\/\/doi.org\/10.1093\/nar\/gkv1266.","DOI":"10.1093\/nar\/gkv1266"},{"issue":"1","key":"855_CR29","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1038\/s41598-019-42456-8","volume":"9","author":"SG Patel","year":"2019","unstructured":"Patel SG, Sayers EJ, He L, Narayan R, Williams TL, Mills EM, et al. Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines. Sci Rep. 2019;9(1):6298. https:\/\/doi.org\/10.1038\/s41598-019-42456-8.","journal-title":"Sci Rep"},{"issue":"2","key":"855_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.peptides.2012.07.019","volume":"37","author":"J-S Liou","year":"2012","unstructured":"Liou J-S, Liu BR, Martin AL, Huang Y-W, Chiang H-J, Lee H-J. Protein transduction in human cells is enhanced by cell-penetrating peptides fused with an endosomolytic HA2 sequence. Peptides. 2012;37(2):273\u201384. https:\/\/doi.org\/10.1016\/j.peptides.2012.07.019.","journal-title":"Peptides"},{"issue":"17","key":"855_CR31","doi-asserted-by":"publisher","first-page":"7934","DOI":"10.1073\/pnas.89.17.7934","volume":"89","author":"E Wagner","year":"1992","unstructured":"Wagner E, Plank C, Zatloukal K, Cotten M, Birnstiel ML. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA. 1992;89(17):7934\u201338. https:\/\/doi.org\/10.1073\/pnas.89.17.7934.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"855_CR32","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.bbamem.2010.09.001","volume":"1798","author":"R Brasseur","year":"2010","unstructured":"Brasseur R, Divita G. Happy birthday cell penetrating peptides: already 20 years. Biochim et Biophys Acta (BBA) - Biomembr. 2010;1798(12):2177\u201381. https:\/\/doi.org\/10.1016\/j.bbamem.2010.09.001.","journal-title":"Biochim et Biophys Acta (BBA) - Biomembr"},{"issue":"4\u20135","key":"855_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.addr.2007.09.005","volume":"60","author":"S Deshayes","year":"2008","unstructured":"Deshayes S, Morris M, Heitz F, Divita G. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv Drug Deliv Rev. 2008;60(4\u20135):537\u201347. https:\/\/doi.org\/10.1016\/j.addr.2007.09.005.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"855_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.fsi.2014.04.003","volume":"39","author":"J Ma","year":"2014","unstructured":"Ma J, Xu J, Guan L, Hu T, Liu Q, Xiao J, et al. Cell-penetrating peptides mediated protein cross-membrane delivery and its use in bacterial vector vaccine. Fish Shellfish Immunol. 2014;39(1):8\u201316. https:\/\/doi.org\/10.1016\/j.fsi.2014.04.003.","journal-title":"Fish Shellfish Immunol"},{"issue":"2","key":"855_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/biom2020187","volume":"2","author":"WL Munyendo","year":"2012","unstructured":"Munyendo WL, Lv H, Benza-Ingoula H, Baraza LD, Zhou J. Cell penetrating peptides in the delivery of biopharmaceuticals. Biomolecules. 2012;2(2):187\u2013202. https:\/\/doi.org\/10.3390\/biom2020187.","journal-title":"Biomolecules"},{"issue":"4","key":"855_CR36","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/ph3040961","volume":"3","author":"S Trabulo","year":"2010","unstructured":"Trabulo S, Cardoso AL, Mano M, De Lima MCP. Cell-penetrating peptides\u2014mechanisms of cellular uptake and generation of delivery systems. Pharmaceuticals. 2010;3(4):961\u201393. https:\/\/doi.org\/10.3390\/ph3040961.","journal-title":"Pharmaceuticals"},{"issue":"3","key":"855_CR37","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1021\/nn4057269","volume":"8","author":"DM Copolovici","year":"2014","unstructured":"Copolovici DM, Langel K, Eriste E, Langel \u00dc. Cell-penetrating peptides: design, synthesis, and applications. ACS Nano. 2014;8(3):1972\u201394. https:\/\/doi.org\/10.1021\/nn4057269.","journal-title":"ACS Nano"},{"issue":"7","key":"855_CR38","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1529\/biophysj.106.100198","volume":"92","author":"LE Yandek","year":"2007","unstructured":"Yandek LE, Pokorny A, Flor\u00e9n A, Knoelke K, Langel \u00dc, Almeida PFF. Mechanism of the cell-penetrating peptide Transportan 10 permeation of lipid bilayers. Biophys J. 2007;92(7):2434\u201344. https:\/\/doi.org\/10.1529\/biophysj.106.100198.","journal-title":"Biophys J"},{"issue":"5","key":"855_CR39","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1073\/pnas.0510611103","volume":"103","author":"J Zielinski","year":"2006","unstructured":"Zielinski J, Kilk K, Peritz T, Kannanayakal T, Miyashiro KY, Eir\u00edksd\u00f3ttir E, et al. In vivo identification of ribonucleoprotein-RNA interactions. Proc Natl Acad Sci USA. 2006;103(5):1557\u201362. https:\/\/doi.org\/10.1073\/pnas.0510611103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"855_CR40","doi-asserted-by":"publisher","unstructured":"Kizil C, Iltzsche A, Thomas AK, Bhattarai P, Zhang Y, Brand M. Efficient cargo delivery into adult brain tissue using short cell-penetrating peptides. PLoS One. 2015;10(4):e0124073. https:\/\/doi.org\/10.1371\/journal.pone.0124073.","DOI":"10.1371\/journal.pone.0124073"},{"issue":"9","key":"855_CR41","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nbt0998-857","volume":"16","author":"M Pooga","year":"1998","unstructured":"Pooga M, Soomets U, H\u00e4llbrink M, Valkna A, Saar K, Rezaei K, et al. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol. 1998;16(9):857\u201361. https:\/\/doi.org\/10.1038\/nbt0998-857.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"855_CR42","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nbt.1541","volume":"27","author":"A Eguchi","year":"2009","unstructured":"Eguchi A, Meade BR, Chang Y-C, Fredrickson CT, Willert K, Puri N, et al. Efficient siRNA delivery into primary cells by a peptide transduction domain\u2013dsRNA binding domain fusion protein. Nat Biotechnol. 2009;27(6):567\u201371. https:\/\/doi.org\/10.1038\/nbt.1541.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"855_CR43","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","volume":"55","author":"AD Frankel","year":"1988","unstructured":"Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell. 1988;55(6):1189\u201393. https:\/\/doi.org\/10.1016\/0092-8674(88)90263-2.","journal-title":"Cell"},{"key":"855_CR44","doi-asserted-by":"publisher","unstructured":"Morris MC, Gros E, Aldrian-Herrada G, Choob M, Archdeacon J, Heitz F, et al. A non-covalent peptide-based carrier for in vivo delivery of DNA mimics. Nucleic Acids Res. 2007;35(7):e49\u201349. https:\/\/doi.org\/10.1093\/nar\/gkm053.","DOI":"10.1093\/nar\/gkm053"},{"issue":"30","key":"855_CR45","doi-asserted-by":"publisher","first-page":"10189","DOI":"10.1021\/bi0502644","volume":"44","author":"ST Henriques","year":"2005","unstructured":"Henriques ST, Costa J, Castanho MARB. Translocation of \u03b2-galactosidase mediated by the cell-penetrating peptide Pep-1 into lipid vesicles and human HeLa cells is driven by membrane electrostatic potential. Biochemistry. 2005;44(30):10189\u201398. https:\/\/doi.org\/10.1021\/bi0502644.","journal-title":"Biochemistry"},{"issue":"6","key":"855_CR46","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/iub.1503","volume":"68","author":"G Mardani","year":"2016","unstructured":"Mardani G, Bolhassani A, Agi E, Shahbazi S, Mehdi Sadat S. Protein vaccination with HPV16 E7\/Pep-1 nanoparticles elicits a protective T-helper cell-mediated immune response. IUBMB Life. 2016;68(6):459\u201367. https:\/\/doi.org\/10.1002\/iub.1503.","journal-title":"IUBMB Life"},{"issue":"12","key":"855_CR47","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.bbamem.2010.02.027","volume":"1798","author":"L Kurzawa","year":"2010","unstructured":"Kurzawa L, Pellerano M, Morris MC. PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells. Biochim et Biophys Acta (BBA) - Biomembr. 2010;1798(12):2274\u201385. https:\/\/doi.org\/10.1016\/j.bbamem.2010.02.027.","journal-title":"Biochim et Biophys Acta (BBA) - Biomembr"},{"key":"855_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ejpb.2017.01.012","volume":"114","author":"N Ponnappan","year":"2017","unstructured":"Ponnappan N, Chugh A. Cell-penetrating and cargo-delivery ability of a spider toxin-derived peptide in mammalian cells. Eur J Criminol Pharm Biopharmaceutics. 2017;114:145\u201353. https:\/\/doi.org\/10.1016\/j.ejpb.2017.01.012.","journal-title":"Eur J Criminol Pharm Biopharmaceutics"},{"key":"855_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3762\/bjnano.11.10","volume":"11","author":"I Ruseska","year":"2020","unstructured":"Ruseska I, Zimmer A. Internalization mechanisms of cell-penetrating peptides. Beilstein J Nanotechnol. 2020;11:101\u201323. https:\/\/doi.org\/10.3762\/bjnano.11.10.","journal-title":"Beilstein J Nanotechnol"},{"key":"855_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/414729","volume":"2011","author":"F Madani","year":"2011","unstructured":"Madani F, Lindberg S, Langel \u00dc, Futaki S, Gr\u00e4slund A. Mechanisms of cellular uptake of cell-penetrating peptides. J Educ Chang Biophys. 2011;2011:1\u201310. https:\/\/doi.org\/10.1155\/2011\/414729.","journal-title":"J Educ Chang Biophys"},{"issue":"4","key":"855_CR51","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5603\/FHC.a2014.0034","volume":"52","author":"J Ruczynski","year":"2015","unstructured":"Ruczynski J, Wierzbicki PM, Kogut-Wierzbicka M, Mucha P, Siedlecka-Kroplewska K, Rekowski P. Cell-penetrating peptides as a promising tool for delivery of various molecules into the cells. Folia Histochem Cytobiol. 2015;52(4):257\u201369. https:\/\/doi.org\/10.5603\/FHC.a2014.0034.","journal-title":"Folia Histochem Cytobiol"},{"issue":"25","key":"855_CR52","doi-asserted-by":"publisher","first-page":"8450","DOI":"10.1021\/bi960342a","volume":"35","author":"K Matsuzaki","year":"1996","unstructured":"Matsuzaki K, Yoneyama S, Murase O, Miyajima K. Transbilayer transport of ions and lipids coupled with Mastoparan X translocation. Biochemistry. 1996;35(25):8450\u201356. https:\/\/doi.org\/10.1021\/bi960342a.","journal-title":"Biochemistry"},{"key":"855_CR53","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.biopha.2018.09.097","volume":"108","author":"H Derakhshankhah","year":"2018","unstructured":"Derakhshankhah H, Jafari S. Cell penetrating peptides: a concise review with emphasis on biomedical applications. Biomed Pharmacother. 2018;108:1090\u201396. https:\/\/doi.org\/10.1016\/j.biopha.2018.09.097.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"855_CR54","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/smll.201100001","volume":"7","author":"F Zhao","year":"2011","unstructured":"Zhao F, Zhao Y, Liu Y, Chang X, Chen C, Zhao Y. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small. 2011;7(10):1322\u201337. https:\/\/doi.org\/10.1002\/smll.201100001.","journal-title":"Small"},{"issue":"41","key":"855_CR55","doi-asserted-by":"publisher","first-page":"16883","DOI":"10.1073\/pnas.1108795108","volume":"108","author":"A Mishra","year":"2011","unstructured":"Mishra A, Lai GH, Schmidt NW, Sun VZ, Rodriguez AR, Tong R, et al. Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions. Proc Natl Acad Sci USA. 2011;108(41):16883\u201388. https:\/\/doi.org\/10.1073\/pnas.1108795108.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"855_CR56","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1582-4934.2007.00062.x","volume":"11","author":"AT Jones","year":"2007","unstructured":"Jones AT. Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides. J Cellular Mol Medi. 2007;11(4):670\u201384. https:\/\/doi.org\/10.1111\/j.1582-4934.2007.00062.x.","journal-title":"J Cellular Mol Medi"},{"issue":"8","key":"855_CR57","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrm2216","volume":"8","author":"S Mayor","year":"2007","unstructured":"Mayor S, Pagano RE. Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol. 2007;8(8):603\u201312. https:\/\/doi.org\/10.1038\/nrm2216.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"855_CR58","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/ijms17020263","volume":"17","author":"A Dinca","year":"2016","unstructured":"Dinca A, Chien W-M, Chin M. Intracellular delivery of proteins with cell-penetrating peptides for therapeutic uses in human Disease. IJMS. 2016;17(2):263. https:\/\/doi.org\/10.3390\/ijms17020263.","journal-title":"IJMS"},{"issue":"23","key":"855_CR59","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S1359-6446(04)03279-9","volume":"9","author":"J Temsamani","year":"2004","unstructured":"Temsamani J, Vidal P. The use of cell-penetrating peptides for drug delivery. Drug Discov. Today Today. 2004;9(23):1012\u201319. https:\/\/doi.org\/10.1016\/S1359-6446(04)03279-9.","journal-title":"Drug Discov. Today Today"},{"key":"855_CR60","doi-asserted-by":"publisher","unstructured":"Torchilin V. Intracellular delivery of protein and peptide therapeutics. Drug Discov Today Technol. 2008;5(2\u20133):e95\u2013103. https:\/\/doi.org\/10.1016\/j.ddtec.2009.01.002.","DOI":"10.1016\/j.ddtec.2009.01.002"},{"issue":"1","key":"855_CR61","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-024-02107-5","volume":"10","author":"W Xiao","year":"2025","unstructured":"Xiao W, Jiang W, Chen Z, Huang Y, Mao J, Zheng W, et al. Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines. Sig Transduct Target Ther. 2025;10(1):74. https:\/\/doi.org\/10.1038\/s41392-024-02107-5.","journal-title":"Sig Transduct Target Ther"},{"issue":"4","key":"855_CR62","doi-asserted-by":"publisher","first-page":"140604","DOI":"10.1016\/j.bbapap.2021.140604","volume":"1869","author":"GC Kim","year":"2021","unstructured":"Kim GC, Cheon DH, Lee Y. Challenge to overcome current limitations of cell-penetrating peptides. Biochim Et Biophys Acta (BBA) - Proteins Proteomics. 2021;1869(4):140604. https:\/\/doi.org\/10.1016\/j.bbapap.2021.140604.","journal-title":"Biochim Et Biophys Acta (BBA) - Proteins Proteomics"},{"issue":"6","key":"855_CR63","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s10989-025-10776-1","volume":"31","author":"A Polak","year":"2025","unstructured":"Polak A, Machnik G, Bu\u0142dak \u0141, W\u00f3jtowicz W, Ruczy\u0144ski J, Prochera K, et al. Application of cell-penetrating peptides (CPP) to enhance the efficacy of Antisense peptide nucleic acids (PNA) molecules delivery. Int J Pept Res Ther. 2025;31(6):114. https:\/\/doi.org\/10.1007\/s10989-025-10776-1.","journal-title":"Int J Pept Res Ther"},{"issue":"11","key":"855_CR64","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.4155\/tde.13.104","volume":"4","author":"BJ Bruno","year":"2013","unstructured":"Bruno BJ, Miller GD, Lim CS. Basics and recent advances in peptide and protein drug delivery. Ther Deliv. 2013;4(11):1443\u201367. https:\/\/doi.org\/10.4155\/tde.13.104.","journal-title":"Ther Deliv"},{"issue":"10","key":"855_CR65","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","volume":"26","author":"JL Lau","year":"2018","unstructured":"Lau JL, Dunn MK. Therapeutic peptides: historical perspectives, current development trends, and future directions. Bioorg Med Chem. 2018;26(10):2700\u201307. https:\/\/doi.org\/10.1016\/j.bmc.2017.06.052.","journal-title":"Bioorg Med Chem"},{"issue":"12","key":"855_CR66","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1021\/acs.biomac.1c00745","volume":"22","author":"JM Horn","year":"2021","unstructured":"Horn JM, Obermeyer AC. Genetic and covalent protein modification strategies to facilitate intracellular delivery. Biomacromolecules. 2021;22(12):4883\u2013904. https:\/\/doi.org\/10.1021\/acs.biomac.1c00745.","journal-title":"Biomacromolecules"},{"issue":"6","key":"855_CR67","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/ange.201711651","volume":"130","author":"L Qian","year":"2018","unstructured":"Qian L, Fu J, Yuan P, Du S, Huang W, Li L, et al. Intracellular delivery of native proteins facilitated by cell-penetrating Poly(disulfide)s. Angew Chem. 2018;130(6):1548\u201352. https:\/\/doi.org\/10.1002\/ange.201711651.","journal-title":"Angew Chem"},{"issue":"29","key":"855_CR68","doi-asserted-by":"publisher","first-page":"8989","DOI":"10.1002\/anie.201804128","volume":"57","author":"H Ungati","year":"2018","unstructured":"Ungati H, Govindaraj V, Mugesh G. The remarkable effect of halogen substitution on the membrane transport of fluorescent molecules in living cells. Angew Chem Int Ed. 2018;57(29):8989\u201393. https:\/\/doi.org\/10.1002\/anie.201804128.","journal-title":"Angew Chem Int Ed"},{"issue":"1","key":"855_CR69","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1038\/s41467-023-38039-x","volume":"14","author":"SB Ebrahimi","year":"2023","unstructured":"Ebrahimi SB, Samanta D. Engineering protein-based therapeutics through structural and chemical design. Nat Commun. 2023;14(1):2411. https:\/\/doi.org\/10.1038\/s41467-023-38039-x.","journal-title":"Nat Commun"},{"issue":"4","key":"855_CR70","doi-asserted-by":"publisher","first-page":"314","DOI":"10.4161\/self.1.4.13904","volume":"1","author":"M Baker","year":"2010","unstructured":"Baker M, Reynolds HM, Lumicisi B, Bryson CJ. Immunogenicity of protein therapeutics: the key causes, consequences and challenges. Self\/Nonself. 2010;1(4):314\u201322. https:\/\/doi.org\/10.4161\/self.1.4.13904.","journal-title":"Self\/Nonself"},{"issue":"7","key":"855_CR71","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.arabjc.2017.05.011","volume":"12","author":"I Khan","year":"2019","unstructured":"Khan I, Saeed K, Khan I. Nanoparticles: properties, applications and toxicities. Arabian J Chem. 2019;12(7):908\u201331. https:\/\/doi.org\/10.1016\/j.arabjc.2017.05.011.","journal-title":"Arabian J Chem"},{"key":"855_CR72","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/B978-0-443-18770-4.00015-9","volume-title":"Current status, challenges, and future perspective of nanomedicine-based cancer immunotherapy","author":"Z Sultana","year":"2024","unstructured":"Sultana Z, Jamil Z, Samanta A, Alam SSM, Ali S, Hoque M. Current status, challenges, and future perspective of nanomedicine-based cancer immunotherapy. Nanomedicine Cancer Immunother., Elsevier; 2024. p. 495\u2013516. https:\/\/doi.org\/10.1016\/B978-0-443-18770-4.00015-9."},{"key":"855_CR73","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jconrel.2015.10.012","volume":"240","author":"M Yu","year":"2016","unstructured":"Yu M, Wu J, Shi J, Farokhzad OC. Nanotechnology for protein delivery: overview and perspectives. J Control Release. 2016;240:24\u201337. https:\/\/doi.org\/10.1016\/j.jconrel.2015.10.012.","journal-title":"J Control Release"},{"issue":"4","key":"855_CR74","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1021\/acs.langmuir.6b04304","volume":"33","author":"S Kube","year":"2017","unstructured":"Kube S, Hersch N, Naumovska E, Gensch T, Hendriks J, Franzen A, et al. Fusogenic liposomes as nanocarriers for the delivery of intracellular proteins. Langmuir. 2017;33(4):1051\u201359. https:\/\/doi.org\/10.1021\/acs.langmuir.6b04304.","journal-title":"Langmuir"},{"key":"855_CR75","doi-asserted-by":"publisher","unstructured":"Chatin B, M\u00e9vel M, Devalli\u00e8re J, Dallet L, Haudebourg T, Peuziat P, et al. Liposome-based Formulation for intracellular delivery of functional proteins. Mol Ther - Nucleic Acids. 2015;4:e244. https:\/\/doi.org\/10.1038\/mtna.2015.17.","DOI":"10.1038\/mtna.2015.17"},{"issue":"1","key":"855_CR76","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.xphs.2017.08.003","volume":"107","author":"Y Okamoto","year":"2018","unstructured":"Okamoto Y, Taguchi K, Yamasaki K, Sakuragi M, Kuroda S, Otagiri M. Albumin-encapsulated liposomes: a novel drug delivery carrier with hydrophobic drugs encapsulated in the Inner aqueous core. J Pharm Sci. 2018;107(1):436\u201345. https:\/\/doi.org\/10.1016\/j.xphs.2017.08.003.","journal-title":"J Pharm Sci"},{"issue":"35","key":"855_CR77","doi-asserted-by":"publisher","first-page":"6768","DOI":"10.1039\/D2TB00271J","volume":"10","author":"H Koide","year":"2022","unstructured":"Koide H, Ochiai H, Suzuki H, Hirata S, Watanabe M, Yonezawa S, et al. Easy preparation of a liposome-mediated protein delivery system by freeze\u2013thawing a liposome\u2013protein complex. J Mater Chem B. 2022;10(35):6768\u201376. https:\/\/doi.org\/10.1039\/D2TB00271J.","journal-title":"J Mater Chem B"},{"issue":"3","key":"855_CR78","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/0975-7406.130965","volume":"6","author":"K Madaan","year":"2014","unstructured":"Madaan K, Kumar S, Poonia N, Lather V, Pandita D. Dendrimers in drug delivery and targeting: drug-dendrimer interactions and toxicity issues. J Pharm Bioall Sci. 2014;6(3):139. https:\/\/doi.org\/10.4103\/0975-7406.130965.","journal-title":"J Pharm Bioall Sci"},{"issue":"6","key":"855_CR79","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1021\/bc0499127","volume":"15","author":"AK Patri","year":"2004","unstructured":"Patri AK, Myc A, Beals J, Thomas TP, Bander NH, Baker JR. Synthesis and in vitro testing of J591 Antibody\u2212Dendrimer conjugates for targeted prostate cancer therapy. Bioconjugate Chem. 2004;15(6):1174\u201381. https:\/\/doi.org\/10.1021\/bc0499127.","journal-title":"Bioconjugate Chem"},{"issue":"30","key":"855_CR80","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1002\/adfm.201501548","volume":"25","author":"S Liang","year":"2015","unstructured":"Liang S, Yang X, Du X, Wang H, Li H, Liu W, et al. Optimizing the size of Micellar nanoparticles for efficient siRNA delivery. Adv Funct Mater. 2015;25(30):4778\u201387. https:\/\/doi.org\/10.1002\/adfm.201501548.","journal-title":"Adv Funct Mater"},{"issue":"4","key":"855_CR81","first-page":"743","volume":"2","author":"B Sarmento","year":"2007","unstructured":"Sarmento B, Martins S, Ferreira D, Souto EB. Oral insulin delivery by means of solid lipid nanoparticles. Int J Nanomed. 2007;2(4):743\u201349.","journal-title":"Int J Nanomed"},{"issue":"6","key":"855_CR82","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1016\/j.actbio.2014.01.033","volume":"10","author":"JU Menon","year":"2014","unstructured":"Menon JU, Ravikumar P, Pise A, Gyawali D, Hsia CCW, Nguyen KT. Polymeric nanoparticles for pulmonary protein and DNA delivery. Acta Biomater. 2014;10(6):2643\u201352. https:\/\/doi.org\/10.1016\/j.actbio.2014.01.033.","journal-title":"Acta Biomater"},{"issue":"21","key":"855_CR83","doi-asserted-by":"publisher","first-page":"18751","DOI":"10.1021\/acsomega.3c00738","volume":"8","author":"M Gaur","year":"2023","unstructured":"Gaur M, Maurya S, Akhtar MS, Yadav AB. Synthesis and evaluation of BSA-Loaded PLGA\u2013chitosan composite nanoparticles for the protein-based drug delivery system. ACS Omega. 2023;8(21):18751\u201359. https:\/\/doi.org\/10.1021\/acsomega.3c00738.","journal-title":"ACS Omega"},{"issue":"41","key":"855_CR84","doi-asserted-by":"publisher","first-page":"12029","DOI":"10.1002\/anie.201506030","volume":"54","author":"W Sun","year":"2015","unstructured":"Sun W, Ji W, Hall JM, Hu Q, Wang C, Beisel CL, et al. Self-assembled DNA nanoclews for the efficient delivery of CRISPR\u2013Cas9 for genome editing. Angew Chem Int Ed. 2015;54(41):12029\u201333. https:\/\/doi.org\/10.1002\/anie.201506030.","journal-title":"Angew Chem Int Ed"},{"issue":"22","key":"855_CR85","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.1021\/ja0486059","volume":"126","author":"NW Shi Kam","year":"2004","unstructured":"Shi Kam NW, Jessop TC, Wender PA, Dai H. Nanotube molecular transporters: internalization of carbon Nanotube\u2212Protein conjugates into mammalian cells. J. Am. Chem. Soc. 2004;126(22):6850\u201351. https:\/\/doi.org\/10.1021\/ja0486059.","journal-title":"J. Am. Chem. Soc"},{"key":"855_CR86","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.2147\/IJN.S81762","volume":"10","author":"X Leng","year":"2015","unstructured":"Leng X, Dong X, Liu L, Zhu D, Zhang H. Transactivator of transcription (TAT) peptide\u2013chitosan functionalized multiwalled carbon nanotubes as a potential drug delivery vehicle for cancer therapy. IJN. 2015;10:3829\u201340. https:\/\/doi.org\/10.2147\/IJN.S81762.","journal-title":"IJN"},{"key":"855_CR87","doi-asserted-by":"publisher","unstructured":"Cheng Q, Blais M-O, Harris G, Jabbarzadeh E. PLGA-Carbon Nanotube conjugates for intercellular delivery of caspase-3 into osteosarcoma cells. PLoS One. 2013;8(12):e81947. https:\/\/doi.org\/10.1371\/journal.pone.0081947.","DOI":"10.1371\/journal.pone.0081947"},{"issue":"1","key":"855_CR88","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.1038\/ncomms6633","volume":"5","author":"DH Han","year":"2014","unstructured":"Han DH, Na H-K, Choi WH, Lee JH, Kim YK, Won C, et al. Direct cellular delivery of human proteasomes to delay tau aggregation. Nat Commun. 2014;5(1):5633. https:\/\/doi.org\/10.1038\/ncomms6633.","journal-title":"Nat Commun"},{"key":"855_CR89","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jconrel.2014.06.037","volume":"192","author":"B Zhang","year":"2014","unstructured":"Zhang B, Luo Z, Liu J, Ding X, Li J, Cai K. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo. J Control Release. 2014;192:192\u2013201. https:\/\/doi.org\/10.1016\/j.jconrel.2014.06.037.","journal-title":"J Control Release"},{"issue":"8","key":"855_CR90","doi-asserted-by":"publisher","first-page":"6667","DOI":"10.1021\/nn402753y","volume":"7","author":"R Tang","year":"2013","unstructured":"Tang R, Kim CS, Solfiell DJ, Rana S, Mout R, Vel\u00e1zquez-Delgado EM, et al. Direct delivery of functional proteins and enzymes to the cytosol using Nanoparticle-Stabilized Nanocapsules. ACS Nano. 2013;7(8):6667\u201373. https:\/\/doi.org\/10.1021\/nn402753y.","journal-title":"ACS Nano"},{"issue":"4","key":"855_CR91","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.biomaterials.2011.10.058","volume":"33","author":"A Kumar","year":"2012","unstructured":"Kumar A, Ma H, Zhang X, Huang K, Jin S, Liu J, et al. Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment. Biomaterials. 2012;33(4):1180\u201389. https:\/\/doi.org\/10.1016\/j.biomaterials.2011.10.058.","journal-title":"Biomaterials"},{"issue":"4","key":"855_CR92","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1021\/nn900079e","volume":"3","author":"DM Eby","year":"2009","unstructured":"Eby DM, Schaeublin NM, Farrington KE, Hussain SM, Johnson GR. Lysozyme catalyzes the formation of Antimicrobial silver nanoparticles. ACS Nano. 2009;3(4):984\u201394. https:\/\/doi.org\/10.1021\/nn900079e.","journal-title":"ACS Nano"},{"issue":"26","key":"855_CR93","doi-asserted-by":"publisher","first-page":"6155","DOI":"10.1016\/j.biomaterials.2012.05.035","volume":"33","author":"J Liu","year":"2012","unstructured":"Liu J, Zhao Y, Guo Q, Wang Z, Wang H, Yang Y, et al. TAT-modified nanosilver for combating multidrug-resistant cancer. Biomaterials. 2012;33(26):6155\u201361. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.05.035.","journal-title":"Biomaterials"},{"issue":"10","key":"855_CR94","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1021\/mp400360q","volume":"10","author":"J Zhang","year":"2013","unstructured":"Zhang J, Shin MC, David AE, Zhou J, Lee K, He H, et al. Long-circulating heparin-functionalized magnetic nanoparticles for potential application as a protein drug delivery platform. Mol. Pharm. 2013;10(10):3892\u2013902. https:\/\/doi.org\/10.1021\/mp400360q.","journal-title":"Mol. Pharm"},{"issue":"7","key":"855_CR95","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1080\/21691401.2017.1373655","volume":"46","author":"J Bai Aswathanarayan","year":"2018","unstructured":"Bai Aswathanarayan J, Rai Vittal R, Muddegowda U. Anticancer activity of metal nanoparticles and their peptide conjugates against human colon adenorectal carcinoma cells. Artif Cells, Nanomed Biotechnol. 2018;46(7):1444\u201351. https:\/\/doi.org\/10.1080\/21691401.2017.1373655.","journal-title":"Artif Cells, Nanomed Biotechnol"},{"issue":"10","key":"855_CR96","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1039\/C8CS00008E","volume":"47","author":"F Scaletti","year":"2018","unstructured":"Scaletti F, Hardie J, Lee Y-W, Luther DC, Ray M, Rotello VM. Protein delivery into cells using inorganic nanoparticle\u2013protein supramolecular assemblies. Chem Soc Rev. 2018;47(10):3421\u201332. https:\/\/doi.org\/10.1039\/C8CS00008E.","journal-title":"Chem Soc Rev"},{"key":"855_CR97","doi-asserted-by":"publisher","unstructured":"Alam SSM, Samanta A, Sultana Z, Jamil Z, Ali S, Hoque M. Liposome-based nanomedicines for cancer immunotherapy. Nanomed Cancer Immunother., Elsevier. 2024;271\u201398. https:\/\/doi.org\/10.1016\/B978-0-443-18770-4.00017-2.","DOI":"10.1016\/B978-0-443-18770-4.00017-2"},{"issue":"1","key":"855_CR98","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","volume":"65","author":"TM Allen","year":"2013","unstructured":"Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36\u201348. https:\/\/doi.org\/10.1016\/j.addr.2012.09.037.","journal-title":"Adv Drug Deliv Rev"},{"key":"855_CR99","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fphar.2015.00286","volume":"6","author":"L Sercombe","year":"2015","unstructured":"Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015;6:6. https:\/\/doi.org\/10.3389\/fphar.2015.00286.","journal-title":"Front Pharmacol"},{"key":"855_CR100","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fbioe.2020.00089","volume":"8","author":"F Moncalvo","year":"2020","unstructured":"Moncalvo F, Martinez Espinoza MI, Cellesi F. Nanosized delivery systems for therapeutic proteins: clinically validated technologies and advanced development strategies. Front Bioeng Biotechnol. 2020;8:89. https:\/\/doi.org\/10.3389\/fbioe.2020.00089.","journal-title":"Front Bioeng Biotechnol"},{"issue":"3","key":"855_CR101","first-page":"297","volume":"1","author":"ML Immordino","year":"2006","unstructured":"Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed. 2006;1(3):297\u2013315.","journal-title":"Int J Nanomed"},{"key":"855_CR102","doi-asserted-by":"publisher","unstructured":"Pattni BS, Chupin VV VV, VP. New developments in Liposomal drug delivery. Chem Rev. 2015;115(19):10938\u201366. https:\/\/doi.org\/10.1021\/acs.chemrev.5b00046.","DOI":"10.1021\/acs.chemrev.5b00046"},{"issue":"10","key":"855_CR103","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1461-5347(99)00203-5","volume":"2","author":"M Liu","year":"1999","unstructured":"Liu M, Fr\u00e9chet JMJ. Designing dendrimers for drug delivery. Pharm Sci Technol Today. 1999;2(10):393\u2013401. https:\/\/doi.org\/10.1016\/S1461-5347(99)00203-5.","journal-title":"Pharm Sci Technol Today"},{"issue":"26","key":"855_CR104","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1039\/C4TB00171K","volume":"2","author":"A-M Caminade","year":"2014","unstructured":"Caminade A-M, Turrin C-O. Dendrimers for drug delivery. J Mater Chem B. 2014;2(26):4055\u201366. https:\/\/doi.org\/10.1039\/C4TB00171K.","journal-title":"J Mater Chem B"},{"issue":"1","key":"855_CR105","doi-asserted-by":"publisher","first-page":"507273","DOI":"10.1155\/2014\/507273","volume":"2014","author":"B Noriega-Luna","year":"2014","unstructured":"Noriega-Luna B, God\u00ednez LA, Rodr\u00edguez FJ, Rodr\u00edguez A, Zald\u00edvar-Lelo De Larrea G, Sosa-Ferreyra CF, et al. Applications of dendrimers in drug delivery agents, diagnosis, therapy, and detection. J Retailing Nanomater. 2014;2014(1):507273. https:\/\/doi.org\/10.1155\/2014\/507273.","journal-title":"J Retailing Nanomater"},{"key":"855_CR106","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1049\/nbt2.12018","volume-title":"Nanomicelles: types, properties and applications in drug delivery","author":"A Bose","year":"2021","unstructured":"Bose A, Roy Burman D, Sikdar B, Patra P. Nanomicelles: types, properties and applications in drug delivery. Vol. 15. IET Nanobiotechnol; 2021. p. 19\u201327. https:\/\/doi.org\/10.1049\/nbt2.12018."},{"issue":"3","key":"855_CR107","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/ph16030433","volume":"16","author":"Q Wang","year":"2023","unstructured":"Wang Q, Atluri K, Tiwari AK, Babu RJ. Exploring the application of Micellar drug delivery systems in cancer Nanomedicine. Pharmaceuticals. 2023;16(3):433. https:\/\/doi.org\/10.3390\/ph16030433.","journal-title":"Pharmaceuticals"},{"issue":"8","key":"855_CR108","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3390\/pharmaceutics13081183","volume":"13","author":"MK Satapathy","year":"2021","unstructured":"Satapathy MK, Yen T-L, Jan J-S, Tang R-D, Wang J-Y, Taliyan R, et al. Solid lipid nanoparticles (SLNs): an advanced drug delivery system targeting brain through BBB. Pharmaceutics. 2021;13(8):1183. https:\/\/doi.org\/10.3390\/pharmaceutics13081183.","journal-title":"Pharmaceutics"},{"key":"855_CR109","doi-asserted-by":"publisher","unstructured":"Badilli U, Gumustas M, Uslu B, Ozkan SA. Lipid-based nanoparticles for dermal drug delivery. Org. Mater. Smart Nanocarriers Drug Deliv., Elsevier. 2018;369\u2013413. https:\/\/doi.org\/10.1016\/B978-0-12-813663-8.00009-9.","DOI":"10.1016\/B978-0-12-813663-8.00009-9"},{"issue":"16","key":"855_CR110","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.3390\/molecules25163731","volume":"25","author":"A Zieli\u0144ska","year":"2020","unstructured":"Zieli\u0144ska A, Carreir\u00f3 F, Oliveira AM, Neves A, Pires B, Venkatesh DN, et al. Polymeric nanoparticles: production, Characterization, toxicology and ecotoxicology. Molecules. 2020;25(16):3731. https:\/\/doi.org\/10.3390\/molecules25163731.","journal-title":"Molecules"},{"issue":"3","key":"855_CR111","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/nano12030354","volume":"12","author":"MM El-Hammadi","year":"2022","unstructured":"El-Hammadi MM, Arias JL. Recent advances in the surface functionalization of PLGA-Based Nanomedicines. Nanomaterials. 2022;12(3):354. https:\/\/doi.org\/10.3390\/nano12030354.","journal-title":"Nanomaterials"},{"issue":"8","key":"855_CR112","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2217\/nnm-2016-0393","volume":"12","author":"M Ray","year":"2017","unstructured":"Ray M, Lee Y-W, Scaletti F, Yu R, Rotello VM. Intracellular delivery of proteins by Nanocarriers. Nanomed (Lond.). 2017;12(8):941\u201352. https:\/\/doi.org\/10.2217\/nnm-2016-0393.","journal-title":"Nanomed (Lond.)"},{"issue":"1","key":"855_CR113","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","volume":"25","author":"CA Lino","year":"2018","unstructured":"Lino CA, Harper JC, Carney JP, Timlin JA. Delivering CRISPR: a review of the challenges and approaches. Drug Deliv. 2018;25(1):1234\u201357. https:\/\/doi.org\/10.1080\/10717544.2018.1474964.","journal-title":"Drug Deliv"},{"key":"855_CR114","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3389\/fphar.2018.01401","volume":"9","author":"D Maiti","year":"2019","unstructured":"Maiti D, Tong X, Mou X, Yang K. Carbon-based nanomaterials for biomedical applications: a recent study. Front Pharmacol. 2019;9:1401. https:\/\/doi.org\/10.3389\/fphar.2018.01401.","journal-title":"Front Pharmacol"},{"issue":"6","key":"855_CR115","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.cbpa.2005.10.005","volume":"9","author":"A Bianco","year":"2005","unstructured":"Bianco A, Kostarelos K, Prato M. Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol. 2005;9(6):674\u201379. https:\/\/doi.org\/10.1016\/j.cbpa.2005.10.005.","journal-title":"Curr Opin Chem Biol"},{"issue":"3","key":"855_CR116","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1039\/C8MH00966J","volume":"6","author":"KD Patel","year":"2019","unstructured":"Patel KD, Singh RK, Kim H-W. Carbon-based nanomaterials as an emerging platform for theranostics. Mater Horiz. 2019;6(3):434\u201369. https:\/\/doi.org\/10.1039\/C8MH00966J.","journal-title":"Mater Horiz"},{"key":"855_CR117","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bioactmat.2022.01.045","volume":"14","author":"Y Wang","year":"2022","unstructured":"Wang Y, Li J, Li X, Shi J, Jiang Z, Zhang CY. Graphene-based nanomaterials for cancer therapy and anti-infections. Bioact Mater. 2022;14:335\u201349. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.01.045.","journal-title":"Bioact Mater"},{"issue":"8","key":"855_CR118","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1021\/ja907887z","volume":"132","author":"P Ghosh","year":"2010","unstructured":"Ghosh P, Yang X, Arvizo R, Zhu Z-J, Agasti SS, Mo Z, et al. Intracellular delivery of a membrane-impermeable enzyme in active form using functionalized Gold nanoparticles. J. Am. Chem. Soc. 2010;132(8):2642\u201345. https:\/\/doi.org\/10.1021\/ja907887z.","journal-title":"J. Am. Chem. Soc"},{"issue":"9","key":"855_CR119","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3390\/ijms17091534","volume":"17","author":"X-F Zhang","year":"2016","unstructured":"Zhang X-F, Liu Z-G, Shen W, Gurunathan S. Silver nanoparticles: synthesis, Characterization, properties, applications, and therapeutic approaches. IJMS. 2016;17(9):1534. https:\/\/doi.org\/10.3390\/ijms17091534.","journal-title":"IJMS"},{"key":"855_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1062562","volume":"2018","author":"J Jiang","year":"2018","unstructured":"Jiang J, Pi J, Cai J. The advancing of Zinc oxide nanoparticles for biomedical applications. Bioinorg Chem Appl. 2018;2018:1\u201318. https:\/\/doi.org\/10.1155\/2018\/1062562.","journal-title":"Bioinorg Chem Appl"},{"issue":"14","key":"855_CR121","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1039\/C6CS00636A","volume":"46","author":"S Behzadi","year":"2017","unstructured":"Behzadi S, Serpooshan V, Tao W, Hamaly MA, Alkawareek MY, Dreaden EC, et al. Cellular uptake of nanoparticles: journey inside the cell. Chem Soc Rev. 2017;46(14):4218\u201344. https:\/\/doi.org\/10.1039\/C6CS00636A.","journal-title":"Chem Soc Rev"},{"key":"855_CR122","doi-asserted-by":"publisher","first-page":"0148","DOI":"10.34133\/research.0148","volume":"6","author":"C Qiu","year":"2023","unstructured":"Qiu C, Xia F, Zhang J, Shi Q, Meng Y, Wang C, et al. Advanced strategies for overcoming Endosomal\/Lysosomal barrier in Nanodrug delivery. Research. 2023;6:0148. https:\/\/doi.org\/10.34133\/research.0148.","journal-title":"Research"},{"issue":"5","key":"855_CR123","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/emmm.200900036","volume":"1","author":"G Parenti","year":"2009","unstructured":"Parenti G. Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics. EMBO Mol Med. 2009;1(5):268\u201379. https:\/\/doi.org\/10.1002\/emmm.200900036.","journal-title":"EMBO Mol Med"},{"issue":"6","key":"855_CR124","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.copbio.2004.09.006","volume":"15","author":"H Wagner","year":"2004","unstructured":"Wagner H, Heit A, Schmitz F, Bauer S. Targeting split vaccines to the endosome improves vaccination. Curr Opin Biotechnol. 2004;15(6):538\u201342. https:\/\/doi.org\/10.1016\/j.copbio.2004.09.006.","journal-title":"Curr Opin Biotechnol"},{"key":"855_CR125","doi-asserted-by":"publisher","unstructured":"Xuan L, Ju Z, Skonieczna M, Zhou P, Huang R. Nanoparticles-induced potential toxicity on human health: applications, toxicity mechanisms, and evaluation models. MedComm. 2023;4(4):e327. https:\/\/doi.org\/10.1002\/mco2.327.","DOI":"10.1002\/mco2.327"},{"issue":"1","key":"855_CR126","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/ijms18010120","volume":"18","author":"A Abdal Dayem","year":"2017","unstructured":"Abdal Dayem A, Hossain M, Lee S, Kim K, Saha S, Yang G-M, et al. The role of reactive oxygen species (ROS) in the biological activities of metallic nanoparticles. IJMS. 2017;18(1):120. https:\/\/doi.org\/10.3390\/ijms18010120.","journal-title":"IJMS"},{"issue":"5","key":"855_CR127","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1039\/c3an01966g","volume":"139","author":"M-S Kim","year":"2014","unstructured":"Kim M-S, Louis KM, Pedersen JA, Hamers RJ, Peterson RE, Heideman W. Using citrate-functionalized TiO2 nanoparticles to study the effect of particle size on zebrafish embryo toxicity. Analyst (Lond). 2014;139(5):964. https:\/\/doi.org\/10.1039\/c3an01966g.","journal-title":"Analyst (Lond)"},{"issue":"1","key":"855_CR128","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/jat.1385","volume":"29","author":"H Yang","year":"2009","unstructured":"Yang H, Liu C, Yang D, Zhang H, Xi Z. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Appl Toxicol. 2009;29(1):69\u201378. https:\/\/doi.org\/10.1002\/jat.1385.","journal-title":"J Appl Toxicol"},{"issue":"8","key":"855_CR129","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.3390\/nano11082130","volume":"11","author":"M Huston","year":"2021","unstructured":"Huston M, DeBella M, DiBella M, Gupta A. Green synthesis of nanomaterials. Nanomaterials. 2021;11(8):2130. https:\/\/doi.org\/10.3390\/nano11082130.","journal-title":"Nanomaterials"},{"issue":"1","key":"855_CR130","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s42269-025-01316-4","volume":"49","author":"MM Abady","year":"2025","unstructured":"Abady MM, Mohammed DM, Soliman TN, Shalaby RA, Sakr FA. Sustainable synthesis of nanomaterials using different renewable sources. Bull Natl Res Cent. 2025;49(1):24. https:\/\/doi.org\/10.1186\/s42269-025-01316-4.","journal-title":"Bull Natl Res Cent"},{"issue":"23","key":"855_CR131","doi-asserted-by":"publisher","first-page":"6056","DOI":"10.3390\/ijms20236056","volume":"20","author":"JW Shreffler","year":"2019","unstructured":"Shreffler JW, Pullan JE, Dailey KM, Mallik S, Brooks AE. Overcoming hurdles in nanoparticle clinical translation: the influence of experimental design and surface modification. IJMS. 2019;20(23):6056. https:\/\/doi.org\/10.3390\/ijms20236056.","journal-title":"IJMS"},{"key":"855_CR132","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3389\/fphar.2018.00790","volume":"9","author":"S Hua","year":"2018","unstructured":"Hua S, De Matos MBC, Metselaar JM, Storm G. Current trends and challenges in the clinical translation of nanoparticulate Nanomedicines: pathways for translational development and commercialization. Front Pharmacol. 2018;9:790. https:\/\/doi.org\/10.3389\/fphar.2018.00790.","journal-title":"Front Pharmacol"},{"issue":"1","key":"855_CR133","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1021\/nn4053827","volume":"8","author":"T-W Chu","year":"2014","unstructured":"Chu T-W, Yang J, Zhang R, Sima M, Kope\u010dek J. Cell surface self-assembly of hybrid nanoconjugates via oligonucleotide hybridization induces apoptosis. ACS Nano. 2014;8(1):719\u201330. https:\/\/doi.org\/10.1021\/nn4053827.","journal-title":"ACS Nano"},{"issue":"4","key":"855_CR134","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1021\/acsnano.8b00797","volume":"12","author":"L Li","year":"2018","unstructured":"Li L, Yang J, Wang J, Kope\u010dek J. Amplification of CD20 cross-linking in Rituximab-Resistant B-Lymphoma cells enhances apoptosis induction by drug-free macromolecular therapeutics. ACS Nano. 2018;12(4):3658\u201370. https:\/\/doi.org\/10.1021\/acsnano.8b00797.","journal-title":"ACS Nano"},{"issue":"1","key":"855_CR135","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","volume":"16","author":"JK Patra","year":"2018","unstructured":"Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16(1):71. https:\/\/doi.org\/10.1186\/s12951-018-0392-8.","journal-title":"J Nanobiotechnol"},{"issue":"22","key":"855_CR136","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1002\/asia.201800849","volume":"13","author":"ND Posey","year":"2018","unstructured":"Posey ND, Tew GN. Associative and dissociative processes in non-covalent polymer-mediated intracellular protein delivery. Chem ? Asian J. 2018;13(22):3351\u201365. https:\/\/doi.org\/10.1002\/asia.201800849.","journal-title":"Chem ? Asian J"},{"issue":"3","key":"855_CR137","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1021\/acs.nanolett.6b04955","volume":"17","author":"H Chang","year":"2017","unstructured":"Chang H, Lv J, Gao X, Wang X, Wang H, Chen H, et al. Rational design of a polymer with robust efficacy for intracellular protein and peptide delivery. Nano Lett. 2017;17(3):1678\u201384. https:\/\/doi.org\/10.1021\/acs.nanolett.6b04955.","journal-title":"Nano Lett"},{"key":"855_CR138","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jconrel.2017.03.387","volume":"254","author":"F Sgolastra","year":"2017","unstructured":"Sgolastra F, Backlund CM, Ilker Ozay E, DeRonde Bm, Minter LM, Tew GN, et al. Sequence segregation improves non-covalent protein delivery. J Control Release. 2017;254:131\u201336. https:\/\/doi.org\/10.1016\/j.jconrel.2017.03.387.","journal-title":"J Control Release"},{"issue":"2","key":"855_CR139","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1021\/acs.bioconjchem.8b00753","volume":"30","author":"C Yu","year":"2019","unstructured":"Yu C, Tan E, Xu Y, Lv J, Cheng Y. A guanidinium-rich polymer for efficient cytosolic delivery of native proteins. Bioconjugate Chem. 2019;30(2):413\u201317. https:\/\/doi.org\/10.1021\/acs.bioconjchem.8b00753.","journal-title":"Bioconjugate Chem"},{"key":"855_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.03.037","volume":"207","author":"J Xu","year":"2019","unstructured":"Xu J, Wang H, Xu L, Chao Y, Wang C, Han X, et al. Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy. Biomaterials. 2019;207:1\u20139. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.03.037.","journal-title":"Biomaterials"},{"issue":"1","key":"855_CR141","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","volume":"307","author":"D Owensiii","year":"2006","unstructured":"Owensiii D, Peppas N. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Multiling Pharm. 2006;307(1):93\u2013102. https:\/\/doi.org\/10.1016\/j.ijpharm.2005.10.010.","journal-title":"Int J Multiling Pharm"},{"issue":"2","key":"855_CR142","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1021\/bm301511w","volume":"14","author":"X Xue","year":"2013","unstructured":"Xue X, Li D, Yu J, Ma G, Su Z, Hu T. Phenyl linker-induced dense PEG conformation improves the efficacy of C-Terminally MonoPEGylated staphylokinase. Biomacromolecules. 2013;14(2):331\u201341. https:\/\/doi.org\/10.1021\/bm301511w.","journal-title":"Biomacromolecules"},{"issue":"3","key":"855_CR143","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10924-011-0317-1","volume":"19","author":"GE Luckachan","year":"2011","unstructured":"Luckachan GE, Pillai CKS. Biodegradable polymers- a review on recent trends and emerging perspectives. J Polym Environ. 2011;19(3):637\u201376. https:\/\/doi.org\/10.1007\/s10924-011-0317-1.","journal-title":"J Polym Environ"},{"key":"855_CR144","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijpharm.2019.03.011","volume":"561","author":"A George","year":"2019","unstructured":"George A, Shah PA, Shrivastav PS. Natural biodegradable polymers based nano-formulations for drug delivery: a review. Int J Multiling Pharm. 2019;561:244\u201364. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.03.011.","journal-title":"Int J Multiling Pharm"},{"issue":"4","key":"855_CR145","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","volume":"116","author":"N Kamaly","year":"2016","unstructured":"Kamaly N, Yameen B, Wu J, Farokhzad OC. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev. 2016;116(4):2602\u201363. https:\/\/doi.org\/10.1021\/acs.chemrev.5b00346.","journal-title":"Chem Rev"},{"issue":"spc","key":"855_CR146","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4333\/KPS.2010.40.S.045","volume":"40","author":"E-S Lee","year":"2010","unstructured":"Lee E-S, Kim J-H, Yun J-M, Lee K-S, Park G-Y, Lee B-J, et al. Functional polymers for drug delivery systems in Nanomedicines. J Pharm Investigation. 2010;40(spc):45\u201361. https:\/\/doi.org\/10.4333\/KPS.2010.40.S.045.","journal-title":"J Pharm Investigation"},{"issue":"1","key":"855_CR147","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1039\/C6PY01585A","volume":"8","author":"M Wei","year":"2017","unstructured":"Wei M, Gao Y, Li X, Serpe MJ. Stimuli-responsive polymers and their applications. Polym. Chem. 2017;8(1):127\u201343. https:\/\/doi.org\/10.1039\/C6PY01585A.","journal-title":"Polym. Chem"},{"issue":"2","key":"855_CR148","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/ma13020366","volume":"13","author":"LC Nelemans","year":"2020","unstructured":"Nelemans LC, Gurevich L. Drug delivery with polymeric nanocarriers\u2014cellular uptake mechanisms. Materials. 2020;13(2):366. https:\/\/doi.org\/10.3390\/ma13020366.","journal-title":"Materials"},{"issue":"7","key":"855_CR149","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/mabi.201300030","volume":"13","author":"J Lee","year":"2013","unstructured":"Lee J, Twomey M, Machado C, Gomez G, Doshi M, Gesquiere AJ, et al. Caveolae-mediated endocytosis of conjugated polymer nanoparticles: Caveolae-mediated endocytosis of conjugated polymer nanoparticles. Macromol Biosci. 2013;13(7):913\u201320. https:\/\/doi.org\/10.1002\/mabi.201300030.","journal-title":"Macromol Biosci"},{"issue":"01","key":"855_CR150","doi-asserted-by":"publisher","first-page":"03","DOI":"10.4172\/2329-6887.1000e127","volume":"03","author":"P Agrawal","year":"2015","unstructured":"Agrawal P. Significance of polymers in drug delivery system. J Pharmacovigil. 2015;03(01):03. https:\/\/doi.org\/10.4172\/2329-6887.1000e127.","journal-title":"J Pharmacovigil"},{"issue":"3","key":"855_CR151","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/adem.201080088","volume":"13","author":"S Grund","year":"2011","unstructured":"Grund S, Bauer M, Fischer D. Polymers in drug delivery\u2014State of the Art and future trends. Adv Eng Mater. 2011;13(3):13. https:\/\/doi.org\/10.1002\/adem.201080088.","journal-title":"Adv Eng Mater"},{"issue":"10","key":"855_CR152","doi-asserted-by":"publisher","first-page":"9689","DOI":"10.1021\/acsnano.7b04630","volume":"11","author":"M Bartneck","year":"2017","unstructured":"Bartneck M, Schl\u00f6\u00dfer CT, Barz M, Zentel R, Trautwein C, Lammers T, et al. Immunomodulatory therapy of inflammatory liver Disease using selectin-binding glycopolymers. ACS Nano. 2017;11(10):9689\u2013700. https:\/\/doi.org\/10.1021\/acsnano.7b04630.","journal-title":"ACS Nano"},{"issue":"13","key":"855_CR153","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1039\/D5NR00071H","volume":"17","author":"TG Floyd","year":"2025","unstructured":"Floyd TG, Gurnani P, Rho JY. Characterisation of polymeric nanoparticles for drug delivery. Nanoscale. 2025;17(13):7738\u201352. https:\/\/doi.org\/10.1039\/D5NR00071H.","journal-title":"Nanoscale"},{"issue":"1","key":"855_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-015-0156-7","volume":"14","author":"E Sulheim","year":"2016","unstructured":"Sulheim E, Baghirov H, Von Haartman E, B\u00f8e A, \u00c5slund AKO, M\u00f8rch Y, et al. Cellular uptake and intracellular degradation of poly(alkyl cyanoacrylate) nanoparticles. J Nanobiotechnol. 2016;14(1):1. https:\/\/doi.org\/10.1186\/s12951-015-0156-7.","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"855_CR155","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s11051-012-0920-7","volume":"14","author":"S Lazzari","year":"2012","unstructured":"Lazzari S, Moscatelli D, Codari F, Salmona M, Morbidelli M, Diomede L. Colloidal stability of polymeric nanoparticles in biological fluids. J Nanopart Res. 2012;14(6):920. https:\/\/doi.org\/10.1007\/s11051-012-0920-7.","journal-title":"J Nanopart Res"},{"issue":"7","key":"855_CR156","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/gels9070523","volume":"9","author":"NH Thang","year":"2023","unstructured":"Thang NH, Chien TB, Cuong DX. Polymer-based hydrogels Applied in drug delivery: an overview. Gels. 2023;9(7):523. https:\/\/doi.org\/10.3390\/gels9070523.","journal-title":"Gels"},{"key":"855_CR157","doi-asserted-by":"publisher","unstructured":"Carter PJ, Lazar GA. Next generation antibody drugs: pursuit of the\u2019high-hanging fruit\u2019. Nat Rev Drug Discov. 2018;17(3):197\u2013223. https:\/\/doi.org\/10.1038\/nrd.2017.227.","DOI":"10.1038\/nrd.2017.227"},{"issue":"2","key":"855_CR158","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/abt\/tbae007","volume":"7","author":"WR Strohl","year":"2024","unstructured":"Strohl WR. Structure and function of therapeutic antibodies approved by the US FDA in 2023. Antibody Ther. 2024;7(2):132\u201356. https:\/\/doi.org\/10.1093\/abt\/tbae007.","journal-title":"Antibody Ther"},{"issue":"23","key":"855_CR159","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/cmdc.201800624","volume":"13","author":"R Fu","year":"2018","unstructured":"Fu R, Carroll L, Yahioglu G, Aboagye EO, Miller PW. Antibody fragment and affibody ImmunoPET imaging agents: radiolabelling strategies and applications. ChemMedChem 2018. 2018;13(23):2466\u201378. https:\/\/doi.org\/10.1002\/cmdc.201800624.","journal-title":"ChemMedChem 2018"},{"issue":"1","key":"855_CR160","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4161\/mabs.2.1.10786","volume":"2","author":"AL Nelson","year":"2010","unstructured":"Nelson AL. Antibody fragments: hope and hype. Mabs-austin. 2010;2(1):77\u201383. https:\/\/doi.org\/10.4161\/mabs.2.1.10786.","journal-title":"Mabs-austin"},{"key":"855_CR161","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3389\/fphar.2018.01208","volume":"9","author":"TA Slastnikova","year":"2018","unstructured":"Slastnikova TA, Ulasov AV, Rosenkranz AA, Sobolev AS. Targeted intracellular delivery of antibodies: the State of the Art. Front Pharmacol. 2018;9:1208. https:\/\/doi.org\/10.3389\/fphar.2018.01208.","journal-title":"Front Pharmacol"},{"issue":"4","key":"855_CR162","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1021\/acs.bioconjchem.9b00025","volume":"30","author":"K Singh","year":"2019","unstructured":"Singh K, Ejaz W, Dutta K, Thayumanavan S. Antibody delivery for intracellular targets: emergent therapeutic potential. Bioconjugate Chem. 2019;30(4):1028\u201341. https:\/\/doi.org\/10.1021\/acs.bioconjchem.9b00025.","journal-title":"Bioconjugate Chem"},{"issue":"1","key":"855_CR163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2211068213494388","volume":"19","author":"JM Meacham","year":"2014","unstructured":"Meacham JM, Durvasula K, Degertekin FL, Fedorov AG. Physical methods for intracellular delivery: practical aspects from Laboratory use to industrial-scale processing. SLAS Technol. 2014;19(1):1\u201318. https:\/\/doi.org\/10.1177\/2211068213494388.","journal-title":"SLAS Technol"},{"issue":"6","key":"855_CR164","doi-asserted-by":"publisher","first-page":"686","DOI":"10.4161\/mabs.21696","volume":"4","author":"SN Joshi","year":"2012","unstructured":"Joshi SN, Butler DC, Messer A. Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodies. Mabs-austin. 2012;4(6):686\u201393. https:\/\/doi.org\/10.4161\/mabs.21696.","journal-title":"Mabs-austin"},{"issue":"2","key":"855_CR165","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ymeth.2004.04.003","volume":"34","author":"R Strube","year":"2004","unstructured":"Strube R. Enhanced intracellular stability of sFv?Fc fusion intrabodies. Methods. 2004;34(2):179\u201383. https:\/\/doi.org\/10.1016\/j.ymeth.2004.04.003.","journal-title":"Methods"},{"issue":"46","key":"855_CR166","doi-asserted-by":"publisher","first-page":"19985","DOI":"10.1073\/pnas.1014074107","volume":"107","author":"DL Mallery","year":"2010","unstructured":"Mallery DL, McEwan WA, Bidgood SR, Towers GJ, Johnson CM, James LC. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci USA. 2010;107(46):19985\u201390. https:\/\/doi.org\/10.1073\/pnas.1014074107.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"S1","key":"855_CR167","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s10875-014-0017-4","volume":"34","author":"RE Watkinson","year":"2014","unstructured":"Watkinson RE, McEwan WA, James LC. Intracellular antibody immunity. J Clin Immunol. 2014;34(S1):30\u201334. https:\/\/doi.org\/10.1007\/s10875-014-0017-4.","journal-title":"J Clin Immunol"},{"issue":"33","key":"855_CR168","doi-asserted-by":"publisher","first-page":"335101","DOI":"10.1088\/1361-6528\/aa7c43","volume":"28","author":"L Gao","year":"2017","unstructured":"Gao L, Han L, Ding X, Xu J, Wang J, Zhu J, et al. An effective intracellular delivery system of monoclonal antibody for treatment of tumors: erythrocyte membrane-coated self-associated antibody nanoparticles. Nanotechnology. 2017;28(33):335101. https:\/\/doi.org\/10.1088\/1361-6528\/aa7c43.","journal-title":"Nanotechnology"},{"issue":"20","key":"855_CR169","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.3390\/molecules25204764","volume":"25","author":"U Hafeez","year":"2020","unstructured":"Hafeez U, Parakh S, Gan HK, Scott AM. Antibody\u2013drug conjugates for cancer therapy. Molecules. 2020;25(20):4764. https:\/\/doi.org\/10.3390\/molecules25204764.","journal-title":"Molecules"},{"issue":"2","key":"855_CR170","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/bcr3621","volume":"16","author":"M Barok","year":"2014","unstructured":"Barok M, Joensuu H, Isola J. Trastuzumab emtansine: mechanisms of action and drug resistance. Breast Cancer Res. 2014;16(2):209. https:\/\/doi.org\/10.1186\/bcr3621.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"855_CR171","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/pharmaceutics14020396","volume":"14","author":"R Sheyi","year":"2022","unstructured":"Sheyi R, De La Torre BG, Albericio F. Linkers: an assurance for controlled delivery of antibody-drug conjugate. Pharmaceutics. 2022;14(2):396. https:\/\/doi.org\/10.3390\/pharmaceutics14020396.","journal-title":"Pharmaceutics"},{"key":"855_CR172","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.smaim.2022.01.009","volume":"3","author":"X Gao","year":"2022","unstructured":"Gao X, Ren E, Liu G. Membrane fusion boosting drug transmembrane delivery. Smart Mater Med. 2022;3:254\u201356. https:\/\/doi.org\/10.1016\/j.smaim.2022.01.009.","journal-title":"Smart Mater Med"},{"issue":"21","key":"855_CR173","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.2217\/nnm-2019-0061","volume":"14","author":"N Heath","year":"2019","unstructured":"Heath N, Osteikoetxea X, De Oliveria TM, L\u00e1zaro-Ib\u00e1\u00f1ez E, Shatnyeva O, Schindler C, et al. Endosomal escape enhancing compounds facilitate functional delivery of extracellular vesicle cargo. Nanomed (Lond.). 2019;14(21):2799\u2013814. https:\/\/doi.org\/10.2217\/nnm-2019-0061.","journal-title":"Nanomed (Lond.)"},{"key":"855_CR174","doi-asserted-by":"publisher","first-page":"1227816","DOI":"10.3389\/fddev.2023.1227816","volume":"3","author":"WM Pardridge","year":"2023","unstructured":"Pardridge WM. Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier. Front. Drug Deliv. 2023;3:1227816. https:\/\/doi.org\/10.3389\/fddev.2023.1227816.","journal-title":"Front. Drug Deliv"},{"issue":"8","key":"855_CR175","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.7150\/thno.72594","volume":"12","author":"Z Chen","year":"2022","unstructured":"Chen Z, Kankala RK, Yang Z, Li W, Xie S, Li H, et al. Antibody-based drug delivery systems for cancer therapy: mechanisms, challenges, and prospects. Theranostics. 2022;12(8):3719\u201346. https:\/\/doi.org\/10.7150\/thno.72594.","journal-title":"Theranostics"},{"key":"855_CR176","doi-asserted-by":"publisher","first-page":"886546","DOI":"10.3389\/fimmu.2022.886546","volume":"13","author":"AN Khan","year":"2022","unstructured":"Khan AN, Chowdhury A, Karulkar A, Jaiswal AK, Banik A, Asija S, et al. Immunogenicity of CAR-T cell therapeutics: evidence, mechanism and mitigation. Front. Immunol. 2022;13:886546. https:\/\/doi.org\/10.3389\/fimmu.2022.886546.","journal-title":"Front. Immunol"},{"issue":"11","key":"855_CR177","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1586\/14787210.2015.1079127","volume":"13","author":"KR Chan","year":"2015","unstructured":"Chan KR, Ong EZ, Mok DZ, Ooi EE. Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases. Expert Rev Anti Infect Ther. 2015;13(11):1351\u201360. https:\/\/doi.org\/10.1586\/14787210.2015.1079127.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"855_CR178","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13045-025-01704-3","volume":"18","author":"R Wang","year":"2025","unstructured":"Wang R, Hu B, Pan Z, Mo C, Zhao X, Liu G, et al. Antibody\u2013drug conjugates (ADCs): current and future biopharmaceuticals. J Hematol OncolJ Hematol Oncol. 2025;18(1):51. https:\/\/doi.org\/10.1186\/s13045-025-01704-3.","journal-title":"J Hematol OncolJ Hematol Oncol"},{"issue":"2","key":"855_CR179","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1089\/jop.2013.0247","volume":"31","author":"T Beydoun","year":"2015","unstructured":"Beydoun T, Deloche C, Perino J, Kirwan B-A, Combette J-M, Behar-Cohen F. Subconjunctival injection of XG-102, a JNK inhibitor peptide, in patients with intraocular inflammation: a safety and tolerability study. J Ocul Pharmacol Th. 2015;31(2):93\u201399. https:\/\/doi.org\/10.1089\/jop.2013.0247.","journal-title":"J Ocul Pharmacol Th"},{"issue":"12","key":"855_CR180","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1021\/bc800194e","volume":"19","author":"J Mueller","year":"2008","unstructured":"Mueller J, Kretzschmar I, Volkmer R, Boisguerin P. Comparison of cellular uptake using 22 CPPs in 4 different cell lines. Bioconjugate Chem. 2008;19(12):2363\u201374. https:\/\/doi.org\/10.1021\/bc800194e.","journal-title":"Bioconjugate Chem"},{"issue":"7","key":"855_CR181","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.bbamem.2007.03.029","volume":"1768","author":"C Palm","year":"2007","unstructured":"Palm C, Jayamanne M, Kjellander M, H\u00e4llbrink M. Peptide degradation is a critical determinant for cell-penetrating peptide uptake. Biochim et Biophys Acta (BBA) - Biomembr. 2007;1768(7):1769\u201376. https:\/\/doi.org\/10.1016\/j.bbamem.2007.03.029.","journal-title":"Biochim et Biophys Acta (BBA) - Biomembr"},{"issue":"1","key":"855_CR182","doi-asserted-by":"publisher","first-page":"2272365","DOI":"10.1080\/16583655.2023.2272365","volume":"17","author":"SK Shahzadi","year":"2023","unstructured":"Shahzadi SK, Abdul Qadir M, Mahmood N, Ahmed M. Pegylation of human interferon-\u03b12b with modified amino acids increases circulation half-life and antiproliferative activity. J Taibah Univ Sci. 2023;17(1):2272365. https:\/\/doi.org\/10.1080\/16583655.2023.2272365.","journal-title":"J Taibah Univ Sci"},{"key":"855_CR183","doi-asserted-by":"publisher","unstructured":"Usmani SS, Bedi G, Samuel JS, Singh S, Kalra S, Kumar P, et al. Thpdb: database of FDA-approved peptide and protein therapeutics. PLoS One. 2017;12(7):e0181748. https:\/\/doi.org\/10.1371\/journal.pone.0181748.","DOI":"10.1371\/journal.pone.0181748"},{"issue":"1","key":"855_CR184","doi-asserted-by":"publisher","first-page":"9408","DOI":"10.1038\/s41598-025-94014-0","volume":"15","author":"M Yu","year":"2025","unstructured":"Yu M, Zhang C, Xu H, Dong Y, Zhu H, Xia C, et al. Design of a novel long-acting insulin analogs by acetylation modification and compared with insulin Icodec. Sci Rep. 2025;15(1):9408. https:\/\/doi.org\/10.1038\/s41598-025-94014-0.","journal-title":"Sci Rep"},{"issue":"1","key":"855_CR185","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1038\/s41598-024-52217-x","volume":"14","author":"P Perumal","year":"2024","unstructured":"Perumal P, Sathakkathulla NA, Kumaran K, Ravikumar R, Selvaraj JJ, Nagendran V, et al. Green synthesis of zinc oxide nanoparticles using aqueous extract of shilajit and their anticancer activity against HeLa cells. Sci Rep. 2024;14(1):2204. https:\/\/doi.org\/10.1038\/s41598-024-52217-x.","journal-title":"Sci Rep"},{"key":"855_CR186","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.actbio.2016.01.018","volume":"33","author":"C-C Cheng","year":"2016","unstructured":"Cheng C-C, Chang F-C, Kao W-Y, Hwang S-M, Liao L-C, Chang Y-J, et al. Highly efficient drug delivery systems based on functional supramolecular polymers: in vitro evaluation. Acta Biomater. 2016;33:194\u2013202. https:\/\/doi.org\/10.1016\/j.actbio.2016.01.018.","journal-title":"Acta Biomater"},{"issue":"7","key":"855_CR187","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/pi.3047","volume":"60","author":"VB Morris","year":"2011","unstructured":"Morris VB, Pillai CKS, Sharma CP. Folic acid-conjugated depolymerized quaternized chitosan as potential targeted gene delivery vector. Polym Int. 2011;60(7):1097\u2013106. https:\/\/doi.org\/10.1002\/pi.3047.","journal-title":"Polym Int"},{"issue":"8","key":"855_CR188","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1049\/mnl.2017.0457","volume":"13","author":"B Saqafi","year":"2018","unstructured":"Saqafi B, Rahbarizadeh F. Effect of PEI surface modification with PEG on cytotoxicity and transfection efficiency. Micro Nano Lett. 2018;13(8):1090\u201395. https:\/\/doi.org\/10.1049\/mnl.2017.0457.","journal-title":"Micro Nano Lett"},{"key":"855_CR189","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.breast.2022.10.007","volume":"66","author":"M Shastry","year":"2022","unstructured":"Shastry M, Jacob S, Rugo HS, Hamilton E. Antibody-drug conjugates targeting TROP-2: clinical development in metastatic breast cancer. The Breast. 2022;66:169\u201377. https:\/\/doi.org\/10.1016\/j.breast.2022.10.007.","journal-title":"The Breast"},{"issue":"19","key":"855_CR190","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1056\/NEJMoa1209124","volume":"367","author":"S Verma","year":"2012","unstructured":"Verma S, Miles D, Gianni L, Krop IE, Welslau M, Baselga J, et al. Trastuzumab emtansine for HER2-positive advanced breast cancer. N Engl J Med. 2012;367(19):1783\u201391. https:\/\/doi.org\/10.1056\/NEJMoa1209124.","journal-title":"N Engl J Med"},{"key":"855_CR191","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2147\/IJN.S175340","volume":"14","author":"S Xu","year":"2018","unstructured":"Xu S, Cui F, Huang D, Zhang D, Zhu A, Sun X, et al. PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells. IJN. 2018;14:17\u201332. https:\/\/doi.org\/10.2147\/IJN.S175340.","journal-title":"IJN"},{"issue":"3","key":"855_CR192","doi-asserted-by":"publisher","first-page":"558","DOI":"10.34172\/apb.2024.046","volume":"14","author":"JO Erebor","year":"2024","unstructured":"Erebor JO, Agboluaje EO, Perkins AM, Krishnakumar M, Ngwuluka N. Targeted hybrid nanocarriers as Co-delivery systems for enhanced cancer therapy. Adv Pharm Bull. 2024;14(3):558\u201373. https:\/\/doi.org\/10.34172\/apb.2024.046.","journal-title":"Adv Pharm Bull"},{"issue":"2","key":"855_CR193","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1021\/acs.chemmater.2c03003","volume":"35","author":"J Gao","year":"2023","unstructured":"Gao J, Karp JM, Langer R, Joshi N. The future of drug delivery. Chem Mater. 2023;35(2):359\u201363. https:\/\/doi.org\/10.1021\/acs.chemmater.2c03003.","journal-title":"Chem Mater"},{"key":"855_CR194","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.actbio.2025.02.056","volume":"196","author":"C-Y Lin","year":"2025","unstructured":"Lin C-Y, Fang J-Y, Hsiao C-Y, Lee C-W, Alshetaili A, Lin Z-C. Dual cell-penetrating peptide-conjugated polymeric nanocarriers for miRNA-205\u20135p delivery in gene therapy of cutaneous squamous cell carcinoma. Acta Biomater. 2025;196:332\u201349. https:\/\/doi.org\/10.1016\/j.actbio.2025.02.056.","journal-title":"Acta Biomater"},{"issue":"8","key":"855_CR195","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1021\/acs.biomac.3c00385","volume":"24","author":"P Kanjilal","year":"2023","unstructured":"Kanjilal P, Singh K, Das R, Matte J, Thayumanavan S. Antibody polymer conjugates (APCs) for active targeted therapeutic delivery. Biomacromolecules. 2023;24(8):3638\u201346. https:\/\/doi.org\/10.1021\/acs.biomac.3c00385.","journal-title":"Biomacromolecules"},{"key":"855_CR196","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jconrel.2017.09.016","volume":"267","author":"SM Kim","year":"2017","unstructured":"Kim SM, Faix PH, Schnitzer JE. Overcoming key biological barriers to cancer drug delivery and efficacy. J Control Release. 2017;267:15\u201330. https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.016.","journal-title":"J Control Release"},{"issue":"17","key":"855_CR197","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3390\/nano15171354","volume":"15","author":"A Abughalia","year":"2025","unstructured":"Abughalia A, Flynn M, Clarke PFA, Fayne D, Gobbo OL. The use of computational approaches to design nanodelivery systems. Nanomaterials. 2025;15(17):1354. https:\/\/doi.org\/10.3390\/nano15171354.","journal-title":"Nanomaterials"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00855-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-026-00855-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00855-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:49:01Z","timestamp":1781682541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-026-00855-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":197,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["855"],"URL":"https:\/\/doi.org\/10.1007\/s43440-026-00855-5","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The figures were created using Microsoft PowerPoint and PyMol.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Software used to create the figures"}},{"value":"The authors declare that Artificial Intelligence (AI) tools were not used in the preparation of this manuscript. The authors take full responsibility for the content, interpretation, and conclusions of this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of AI use"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}